[开放获取]    医用重组人源化胶原蛋白在面部年轻化中的应用专家建议（2026版）

doi:10.35541/cjd.20250171

中华皮肤科杂志 ›› 2026, Vol. 59 ›› Issue (4): 320-326.doi: 10.35541/cjd.20250171

[开放获取] 医用重组人源化胶原蛋白在面部年轻化中的应用专家建议（2026版）

中国整形美容协会皮肤美容分会中国非公立医疗机构协会皮肤专业委员会

中国整形美容协会皮肤美容分会中国非公立医疗机构协会皮肤专业委员会

收稿日期:2025-04-01 修回日期:2025-06-25 发布日期:2026-04-03
通讯作者: 项蕾红 E-mail:flora_xiang@vip.163.com

Expert recommendations on the application of medical recombinant humanized collagens in facial rejuvenation （2026 edition）

Society of Aesthetic Dermatology, Chinese Association of Plastics and Aesthetics; Dermatology Committee, Chinese Non-government Medical Institutions Association

Society of Aesthetic Dermatology, Chinese Association of Plastics and Aesthetics; Dermatology Committee, Chinese Non-government Medical Institutions Association

Received:2025-04-01 Revised:2025-06-25 Published:2026-04-03
Contact: Xiang Leihong E-mail:flora_xiang@vip.163.com

摘要/Abstract

摘要： 【摘要】胶原蛋白在预防和治疗面部皮肤老化中具有重要作用，随着医美需求者对年轻化治疗需求的不断增加，医用重组人源化胶原蛋白因其在高安全性和高生物活性方面的潜力而备受关注。为更好地规范和指导医用重组人源化胶原蛋白在面部年轻化中的应用，中国整形美容协会皮肤美容分会和中国非公立医疗机构协会皮肤专业委员会专家组经共同讨论，制订本建议，内容涵盖重组人源化胶原蛋白的分类及定义、作用机制、在面部年轻化的临床应用、与其他技术联合应用、不良反应处理建议及疗效影响因素等，以期为临床应用的规范管理提供指导。

关键词: 医用重组人源化胶原蛋白, 面部, 年轻化, 治疗, 专家共识

Abstract: 【Abstract】 Collagen plays a significant role in the prevention and treatment of facial skin aging. With the increasing demand for rejuvenation among beauty seekers, medical recombinant humanized collagens have attracted much attention due to their characteristics of high safety and biological activity. To better standardize and guide the application of medical recombinant humanized collagens in facial rejuvenation, the expert panel from the Society of Aesthetic Dermatology of Chinese Association of Plastics and Aesthetics and the Dermatology Committee of Chinese Non-government Medical Institutions Association formulated this expert recommendation after joint discussion. The recommendation includes the definition, classification, mechanisms of action, and clinical application (either alone or in combination with other techniques) of recombinant humanized collagens in facial rejuvenation, as well as the management of related adverse reactions and factors influencing therapeutic efficacy, with the aim of providing guidance for the standardized management of their clinical applications.

Key words: Medical recombinant humanized collagen, Facial, Rejuvenation, Treatment, Expert consensus

中国整形美容协会皮肤美容分会中国非公立医疗机构协会皮肤专业委员会. [开放获取] 医用重组人源化胶原蛋白在面部年轻化中的应用专家建议（2026版）[J]. 中华皮肤科杂志, 2026,59(4):320-326. doi:10.35541/cjd.20250171

Society of Aesthetic Dermatology, Chinese Association of Plastics and Aesthetics, Dermatology Committee, Chinese Non-government Medical Institutions Association. Expert recommendations on the application of medical recombinant humanized collagens in facial rejuvenation （2026 edition）[J]. Chinese Journal of Dermatology, 2026, 59(4): 320-326.doi:10.35541/cjd.20250171

参考文献 29

［1］	Shin J, Kwon S, Choi J, et al. Molecular mechanisms of dermal aging and antiaging approaches［J］. Int J Mol Sci, 2019,20（9）:2126. DOI: 10.3390/ijms20092126.
［2］	Poon F, Kang S, Chien AL. Mechanisms and treatments of photoaging［J］. Photodermatol Photoimmunol Photomed, 2015,31（2）:65⁃74. DOI: 10.1111/phpp.12145.
［3］	Li L, Ngo HTT, Hwang E, et al. Conditioned medium from human adipose⁃derived mesenchymal stem cell culture prevents UVB⁃induced skin aging in human keratinocytes and dermal fibroblasts［J］. Int J Mol Sci, 2019,21（1）:49. DOI: 10.3390/ijms21010049.
［4］	Wang J, Qiu H, Xu Y, et al. The biological effect of recombinant humanized collagen on damaged skin induced by UV⁃photoaging: an in vivo study［J］. Bioact Mater, 2022,11:154⁃165. DOI: 10.1016/j.bioactmat.2021.10.004.
［5］	Hua C, Zhu Y, Xu W, et al. Characterization by high⁃resolution crystal structure analysis of a triple⁃helix region of human collagen type Ⅲ with potent cell adhesion activity［J］. Biochem Biophys Res Commun, 2019,508（4）:1018⁃1023. DOI: 10.1016/j.bbrc.2018.12.018.
［6］	Jia Y, Qiu L, Zhang H, et al. Efficacy and safety of typeⅢcollagen lyophilized fibers using mid⁃to⁃deep dermal facial injections for the correction of dynamic facial wrinkles［J］. Aesthetic Plast Surg, 2024,48（13）:2500⁃2512. DOI: 10.1007/s00266⁃023⁃03838⁃6.
［7］	曹力登, 邱禾, 刘硕, 等. 微针注射重组Ⅲ型人源化胶原蛋白对皮肤年轻化的效果［J］. 中华医学美学美容杂志, 2022,28（4）:300⁃303. DOI: 10.3760/cma.j.issn.1671⁃0290.2022.04.012.
［8］	国家药品监督管理局. YY/T1954—2025 重组胶原蛋白肽图指纹图谱分析［S］ . 北京: 国家药品监督管理局, 2025.
［9］	国家药品监督管理局医疗器械标准管理中心. 重组胶原蛋白生物材料命名指导原则［EB/OL］. （2021⁃03⁃15）［2024⁃06⁃05］. https://www.nmpa.gov.cn/xxgk/ggtg/ylqxggtg/ylqxqtggtg/20210315175109170.html.
［10］	国家药品监督管理局. YY/T 1849—2022 重组胶原蛋白［S］. 北京: 国家药品监督管理局, 2022.
［11］	国家药品监督管理局. YY/T 1888—2023 重组人源化胶原蛋白［S］. 北京: 国家药品监督管理局, 2023.
［12］	国家药品监督管理局医疗器械标准管理中心. 《重组胶原蛋白生物材料命名指导原则》解读［EB/OL］. （2023⁃01⁃29）［2024⁃06⁃05］. https://www.nifdc.org.cn/nifdc/bshff/ylqxbzhgl/qxggtzh/ggqt/20230129133404449638.html.
［13］	Bai M, Kang N, Xu Y, et al. The influence of tag sequence on recombinant humanized collagen （rhCol） and the evaluation of rhCol on Schwann cell behaviors［J］. Regen Biomater, 2023,10:rbad089. DOI: 10.1093/rb/rbad089.
［14］	于皓玥, 章婧, 蔄茂强, 等. 真皮衰老与成纤维细胞老化关系的研究进展［J］. 皮肤科学通报, 2023,40（5）:559⁃563+578.
［15］	Baumann L. Collagen⁃containing fillers: alone and in combination［J］. Clin Plast Surg, 2006,33（4）:587⁃596. DOI: 10. 1016/j.cps.2006.08.001.
［16］	Kuivaniemi H, Tromp G. Type Ⅲ collagen （COL3A1）: gene and protein structure, tissue distribution, and associated diseases［J］. Gene, 2019,707:151⁃171. DOI: 10.1016/j.gene.2019.05.003.
［17］	荣艳华, 张国安, 王成, 等. 不同年龄组人正常皮肤Ⅰ型和Ⅲ型胶原含量的比较［J］. 中华烧伤杂志, 2008,（1）:3. DOI: 10.3760/cma.j.issn.1009⁃2587.2008.01.016.
［18］	Russell⁃Goldman E, Murphy GF. The pathobiology of skin aging: new insights into an old dilemma［J］. Am J Pathol, 2020,190（7）:1356⁃1369. DOI: 10.1016/j.ajpath.2020.03.007.
［19］	Fisher G, Rittié L. Restoration of the basement membrane after wounding: a hallmark of young human skin altered with aging［J］. J Cell Commun Signal, 2018,12（1）:401⁃411. DOI: 10.1007/s12079⁃017⁃0417⁃3.
［20］	Langton AK, Halai P, Griffiths CEM, et al. The impact of intrinsic ageing on the protein composition of the dermal⁃epidermal junction［J］. Mech Ageing Dev, 2016,156:14⁃16. DOI: 10.1016/j.mad.2016.03.006.
［21］	Liu N, Matsumura H, Kato T, et al. Stem cell competition orchestrates skin homeostasis and ageing［J］. Nature, 2019,568（7752）:344⁃350. DOI: 10.1038/s41586⁃019⁃1085⁃7.
［22］	You S, Liu S, Dong X, et al. Intravaginal administration of human type Ⅲ collagen⁃derived biomaterial with high cell⁃adhesion activity to treat vaginal atrophy in rats［J］. ACS Biomater Sci Eng, 2020,6（4）:1977⁃1988. DOI: 10.1021/acsbiomaterials.9b01649.
［23］	You S, Zhu Y, Li H, et al. Recombinant humanized collagen remodels endometrial immune microenvironment of chronic endometritis through macrophage immunomodulation［J］. Regen Biomater, 2023,10:rbad033. DOI: 10.1093/rb/rbad033.
［24］	Wang J, Hu H, Wang J, et al. Characterization of recombinant humanized collagen type Ⅲ and its influence on cell behavior and phenotype［J］. J Leather Sci Eng, 2022,4:33.DOI: 10.1186/s42825⁃022⁃00103⁃5.
［25］	Humphrey JD, Dufresne ER, Schwartz MA. Mechanotransduction and extracellular matrix homeostasis［J］. Nat Rev Mol Cell Biol, 2014,15（12）:802⁃812. DOI: 10.1038/nrm3896.
［26］	严蕾, 杜娟, 余凡, 等. 重组Ⅲ型人源化胶原蛋白水光注射技术的操作规范［J］. 中国医疗美容, 2023,13（3）:56⁃60. DOI: 10.19593/j.issn.2095⁃0721.2023.03.009.
［27］	吴艳. 美塑疗法在皮肤美容中应用的专家共识［J］. 中国美容医学, 2020,29（8）:44⁃48. DOI: 10.15909/j.cnki.cn61⁃1347/r. 003866.
［28］	中华医学会皮肤性病学分会皮肤激光医疗美容学组, 中华医学会皮肤性病学分会激光技术应用研究中心, 中华医学会医学美学与美容学分会. 微针治疗临床应用中国专家共识（2022版）［J］. 实用皮肤病学杂志, 2022,15（4）:193⁃196. DOI: 10.11786/sypfbxzz.1674⁃1293.20220401.
［29］	Kim JH, Kwon T, Hong SW, et al. Comparative evaluation of the biodegradability and wrinkle reduction efficacy of human⁃derived collagen filler and hyaluronic acid filler［J］. Aesthetic Plast Surg, 2019,43（4）:1095⁃1101. DOI: 10.1007/s00266⁃019⁃01373⁃x.

[1]	陈雪张建中. [开放获取] 慢性手部湿疹：流行病学、疾病负担、发病机制及管理[J]. 中华皮肤科杂志, 2026, 59(4): 327-332.
[2]	薛舒月李婷婷康晓静. 脂质代谢在皮肤恶性肿瘤发生发展及诊疗中的研究进展 [J]. 中华皮肤科杂志, 2026, 59(4): 379-382.
[3]	黄祺甯马银超王子元鲁锡霖齐映婷刘孜妍门月华初明张春雷. 黄连素软膏对特应性皮炎样小鼠皮肤炎症及菌群的影响作用[J]. 中华皮肤科杂志, 2026, 59(4): 353-360.
[4]	中华医学会皮肤性病学分会儿童学组中国康复医学会皮肤病康复专业委员会儿童皮肤病学组中国医师协会皮肤科医师分会儿童皮肤病学组中国中药协会儿童健康与药物研究专业委员会外治疗法学组中国医师协会儿科分会皮肤病学组 . 中国儿童斑秃诊断和治疗专家共识（2026版）[J]. 中华皮肤科杂志, 2026, 59(4): 291-303.
[5]	中国医学装备协会皮肤病与皮肤美容分会中国临床肿瘤学会患者教育专家委员会. [开放获取] 肿瘤治疗相关皮肤不良反应多学科管理中国专家共识（2026版）[J]. 中华皮肤科杂志, 2026, 59(4): 304-319.
[6]	刘佳谷映桦贺小宁. 遗传性血管性水肿治疗方式与疾病负担研究进展[J]. 中华皮肤科杂志, 2026, 59(3): 282-286.
[7]	曾莞欣文翔. 增生性瘢痕的光电治疗进展[J]. 中华皮肤科杂志, 2026, 59(3): 269-273.
[8]	范慧琳赵慧敏彭依然汪犇黄莹雪赵志祥唐言简丹. 低能量CO2点阵激光治疗玫瑰痤疮难治性持续性红斑的回顾性研究[J]. 中华皮肤科杂志, 2026, 59(3): 218-223.
[9]	朱芸王建才杨明顾菲张洪丽高莹. 755 nm皮秒激光治疗儿童咖啡牛奶斑的疗效及影响因素分析[J]. 中华皮肤科杂志, 2026, 59(3): 224-229.
[10]	夏志宽葛格. [开放获取] 白癜风激光治疗临床应用与展望[J]. 中华皮肤科杂志, 2026, 59(3): 213-217.
[11]	中华医学会皮肤性病学分会银屑病专业委员会. 伴共病的银屑病管理共识（2026版）[J]. 中华皮肤科杂志, 2026, 59(3): 193-207.
[12]	“Chinese expert consensus on the clinical application of photobiomodulation therapy in dermatology ”解读专家组中华医学会皮肤性病学分会激光学组. [开放获取] 2025版光生物调节疗法在皮肤科的临床应用中国专家共识要点解读[J]. 中华皮肤科杂志, 2026, 59(3): 208-212.
[13]	王钧程刘洁. [开放获取] 人工智能在银屑病临床诊疗与患者管理中的应用进展[J]. 中华皮肤科杂志, 2026, 0(3): 20240061-e20240061.
[14]	王丽王千秋张瑞丽. 隐性梅毒研究进展[J]. 中华皮肤科杂志, 2026, 59(3): 286-289.
[15]	许国康蔡梅. 索立德吉治疗局部晚期基底细胞癌8例临床分析[J]. 中华皮肤科杂志, 2026, 59(2): 166-169.

[开放获取] 医用重组人源化胶原蛋白在面部年轻化中的应用专家建议（2026版）

Expert recommendations on the application of medical recombinant humanized collagens in facial rejuvenation （2026 edition）

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 29

相关文章 15

Metrics

本文评价

推荐阅读 10